会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • NUCLEIC ACID ENCODING PROTEINS INVOLVED IN PROTEIN DEGRADATION, PRODUCTS AND METHODS RELATED THERETO
    • 涉及蛋白质降解的产品和方法涉及的核酸编码蛋白
    • US20090181005A1
    • 2009-07-16
    • US12397468
    • 2009-03-04
    • John C. ReedShu-ichi Matsuzawa
    • John C. ReedShu-ichi Matsuzawa
    • A61K38/46C12N9/96
    • C07K14/00C07K14/47C07K2319/00C12N9/88C12Y401/01017
    • In accordance with the present invention, there are provided novel Siah-Mediated-Degradation-Proteins (SMDPS) and/or SCF-Complex Proteins (SCPs). Nucleic acid sequences encoding such proteins and assays employing same are also disclosed. The invention SMDPs and/or SCPs can be employed in a variety of ways, for example, for the production of anti-SMDP and/or SCP antibodies thereto, in therapeutic compositions, and methods employing such proteins and/or antibodies for drug screening, functional genomics and other applications. Also provided are transgenic non-human mammals that express the invention protein. Also provided are compositions and methods for targeting the destruction of selected polypeptides in eukaryotic cells based on the ubiquitin-independent mechanism by which ornithine decarboxylase is degraded by the 26S proteasome.
    • 根据本发明,提供了新型的Siah介导的降解蛋白(SMDPS)和/或SCF-复合蛋白(SCP)。 还公开了编码这种蛋白质的核酸序列和使用其的测定法。 本发明SMDP和/或SCP可以以各种方式使用,例如用于在治疗组合物中生产抗SMDP和/或SCP抗体,以及使用这种蛋白质和/或抗体进行药物筛选的方法, 功能基因组学等应用。 还提供了表达本发明蛋白质的转基因非人哺乳动物。 还提供了基于鸟氨酸脱羧酶被26S蛋白酶体降解的泛素非依赖性机制,靶向真核细胞中所选多肽的破坏的组合物和方法。
    • 2. 发明授权
    • Nucleic acid encoding proteins involved in protein degradation, products and methods related thereof
    • 涉及蛋白质降解的核酸编码蛋白质,与其有关的产品和方法
    • US07504253B2
    • 2009-03-17
    • US11441688
    • 2006-05-25
    • John C. ReedShu-ichi Matsuzawa
    • John C. ReedShu-ichi Matsuzawa
    • C12N5/00C07H17/00C12P14/44
    • C07K14/00C07K14/47C07K2319/00C12N9/88C12Y401/01017
    • In accordance with the present invention, there are provided novel Siah-Mediated-Degradation-Proteins (SMDPs) and/or SCF-Complex Proteins (SCPs). Nucleic acid sequences encoding such proteins and assays employing same are also disclosed. The invention SMDPs and/or SCPs can be employed in a variety of ways, for example, for the production of anti-SMDP and/or SCP antibodies thereto, in therapeutic compositions, and methods employing such proteins and/or antibodies for drug screening, functional genomics and other applications. Also provided are transgenic non-human mammals that express the invention protein. Also provided are compositions and methods for targeting the destruction of selected polypeptides in eukaryotic cells based on the ubiquitin-independent mechanism by which ornithine decarboxylase is degraded by the 26S proteasome.
    • 根据本发明,提供了新型的Siah介导的降解蛋白(SMDP)和/或SCF-复合蛋白(SCP)。 还公开了编码这种蛋白质的核酸序列和使用其的测定法。 本发明SMDP和/或SCP可以以各种方式使用,例如用于在治疗组合物中生产抗SMDP和/或SCP抗体,以及使用这种蛋白质和/或抗体进行药物筛选的方法, 功能基因组学等应用。 还提供了表达本发明蛋白质的转基因非人哺乳动物。 还提供了基于鸟氨酸脱羧酶被26S蛋白酶体降解的泛素非依赖性机制,靶向真核细胞中所选多肽的破坏的组合物和方法。
    • 5. 发明授权
    • Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto
    • 涉及蛋白质降解的核酸编码蛋白质,与其有关的产品和方法
    • US07982002B2
    • 2011-07-19
    • US12397468
    • 2009-03-04
    • John C. ReedShu-ichi Matsuzawa
    • John C. ReedShu-ichi Matsuzawa
    • C07K14/00
    • C07K14/00C07K14/47C07K2319/00C12N9/88C12Y401/01017
    • In accordance with the present invention, there are provided novel Siah-Mediated-Degradation-Proteins (SMDPS) and/or SCF-Complex Proteins (SCPs). Nucleic acid sequences encoding such proteins and assays employing same are also disclosed. The invention SMDPs and/or SCPs can be employed in a variety of ways, for example, for the production of anti-SMDP and/or SCP antibodies thereto, in therapeutic compositions, and methods employing such proteins and/or antibodies for drug screening, functional genomics and other applications. Also provided are transgenic non-human mammals that express the invention protein. Also provided are compositions and methods for targeting the destruction of selected polypeptides in eukaryotic cells based on the ubiquitin-independent mechanism by which ornithine decarboxylase is degraded by the 26S proteasome.
    • 根据本发明,提供了新型的Siah介导的降解蛋白(SMDPS)和/或SCF-复合蛋白(SCP)。 还公开了编码这种蛋白质的核酸序列和使用其的测定法。 本发明SMDP和/或SCP可以以各种方式使用,例如用于在治疗组合物中生产抗SMDP和/或SCP抗体,以及使用这种蛋白质和/或抗体进行药物筛选的方法, 功能基因组学等应用。 还提供了表达本发明蛋白质的转基因非人哺乳动物。 还提供了基于鸟氨酸脱羧酶被26S蛋白酶体降解的泛素非依赖性机制,靶向真核细胞中所选多肽的破坏的组合物和方法。
    • 9. 发明申请
    • Nucleic acid encoding proteins involved in protein degradation, products and methods related thereof
    • 涉及蛋白质降解的核酸编码蛋白质,与其有关的产品和方法
    • US20070042463A1
    • 2007-02-22
    • US11441688
    • 2006-05-25
    • John ReedShu-ichi Matsuzawa
    • John ReedShu-ichi Matsuzawa
    • C12P21/06C12N9/88C07H21/04
    • C07K14/00C07K14/47C07K2319/00C12N9/88C12Y401/01017
    • In accordance with the present invention, there are provided novel Siah-Mediated-Degradation-Proteins (SMDPs) and/or SCF-Complex Proteins (SCPs). Nucleic acid sequences encoding such proteins and assays employing same are also disclosed. The invention SMDPs and/or SCPs can be employed in a variety of ways, for example, for the production of anti-SMDP and/or SCP antibodies thereto, in therapeutic compositions, and methods employing such proteins and/or antibodies for drug screening, functional genomics and other applications. Also provided are transgenic non-human mammals that express the invention protein. Also provided are compositions and methods for targeting the destruction of selected polypeptides in eukaryotic cells based on the ubiquitin-independent mechanism by which ornithine decarboxylase is degraded by the 26S proteasome.
    • 根据本发明,提供了新型的Siah介导的降解蛋白(SMDP)和/或SCF-复合蛋白(SCP)。 还公开了编码这种蛋白质的核酸序列和使用其的测定法。 本发明SMDP和/或SCP可以以各种方式使用,例如用于在治疗组合物中生产抗SMDP和/或SCP抗体,以及使用这种蛋白质和/或抗体进行药物筛选的方法, 功能基因组学等应用。 还提供了表达本发明蛋白质的转基因非人哺乳动物。 还提供了基于鸟氨酸脱羧酶被26S蛋白酶体降解的泛素非依赖性机制,靶向真核细胞中所选多肽的破坏的组合物和方法。